MHRA

MHRA consults on Nuromol P to GSL switch

The MHRA has launched a consultation on whether Nuromol should be available to patients without having to visit a pharmacy.

Some batches of Syonell 250mg and 500mg gastro-resistant tablets have product packaging information errors.

Current data suggests that incidence of cerebral blood clots is around 4 per million first doses of the AZ vaccine.

Five people are suspected of selling unlicensed medicines through illegal websites.

Batches of Itraconazole 10mg/ml oral solution have been recalled by the MHRA.

Most reports relate to injection site reactions and generalised symptoms reflecting a normal immune response to the vaccine.

Making the contraceptive pill available over the counter will increase access and “enable women to make an informed choice" says RPS.

Pharmacists could be able to sell the contraceptive pill after MHRA consultation on reclassification.

The MHRA has said an analysis on approved Covid vaccines shows they are safe despite mild side-effects.

A batch of Instanyl 100mcg nasal spray solution has been recalled following safety concerns.

The MHRA has granted a ‘promising innovative medicine’ designation to experimental RSV drug nirsevimab.

Safety review by MHRA concludes lamotrigine and levetiracetam safer than other antiepileptics for pregnant women.

The MHRA has approved the Moderna vaccine for Covid-19, the third vaccine against the virus to be approved for use in the UK.

Allevia 120mg tablets, which are used to relieve the symptoms of seasonal allergic rhinitis, have been switched from POM to GSL.

Anyone in Northern Ireland selling medicines online must still comply with EU requirements

Potential drug interaction between rivaroxaban and erythromycin resulting in increased risk of bleeding identified

Pharmacists can alleviate people's fears about taking the Covid-19 vaccine, Thorrun Govind told the BBC.

The MHRA has recalled batches of betahistine dihydrochloride tablets.

A drug used to treat sleep disorders carries a risk of birth defects when taken in pregnancy.

The MHRA has asked pharmacists for views on the possible risks associated with the acne medicine isotretinoin.